key: cord-0746713-ur6e87wg
authors: Al-Namaeh, Mashael
title: Ocular manifestations of COVID-19
date: 2022-04-12
journal: Ther Adv Ophthalmol
DOI: 10.1177/25158414221083374
sha: 21eb05f4b7cc3d7514a6b35c4c36351db733b737
doc_id: 746713
cord_uid: ur6e87wg

COVID-19 is a disease caused by a SARS-CoV-2 viral infection, a disease that was first detected in December 2019 in Wuhan, Hubei Province, China. COVID-19, formerly known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease, was officially named COVID-19 by the World Health Organization (WHO) in February 2020. By 25 May 2021, there were 33,579,116 confirmed cases with 599,109 COVID-19 deaths worldwide. The purpose of this review article is to provide an update on what is currently known about COVID-19 ocular symptoms in adults, the elderly, and children in the literature. Finally, this article will review the eye protection precautions that should be implemented in our clinics. To assess the current literature, PubMed was searched from December 2019 to 25 May 2021. Randomized trials, observational studies, case series or case reports, letters of research, and letters to editors were selected for confirmed cases of COVID-19. According to current scientific literature since the outbreak in December 2019, 205 articles have been published. Conjunctivitis, conjunctival hyperemia, and chemosis have been reported in adults with COVID-19. There have been few studies on children and elderly patients, and further research in these age groups is needed. Finally, wearing eye protection when seeing patients on a daily basis during the pandemic is essential.

Conjunctival irritation was the most prevalent ophthalmological finding (50.8%), followed by diplopia (27.8%) and cotton wool patches (27.8%). 14 Males have been diagnosed with viral conjunctivitis at a higher rate than females. 15 The majority of the cases were acute COVID-19 cases, with some chronic COVID-19 cases observed in each case. Chronic COVID-19 cases have been termed 'Long COVID' or 'COVID Long-Haulers'. 16 In China, Long COVID-19 has been reported, with COVID-19 symptoms lasting 6 months after the hospital discharge. 17 A number of literature reviews in ocular manifestations have been published, 13 and couple of the review articles concluded that further studies are required to determine the ocular manifestations in children and geriatric patients. 13 This article will examine the gaps by including ocular manifestations in children and geriatric patients, in addition to currently reported ocular manifestations in adults. Finally, the eye protection precautions that should be applied in our clinics will be covered.

PubMed search was performed from December 2019 to 25 May 2021. The key words 'COVID-19', 'Ocular Manifestations' and 'SARS-COV-2' were used individually or in combination. Randomized trials, observational studies, case series or case reports, letters of research, and letters to editors for confirmed cases of COVID-19 were covered. According to current scientific literature since the outbreak in December 2019, 205 papers have been written (Figure 1 ).

Anterior segment According to several studies, ocular symptoms are uncommon and unlikely to represent the presenting clinical impression in COVID-19 infection. 19 Furthermore, no epiphora, no secretion, or decreased vision has been reported. 20 Other studies concluded no eye problem reports in Thailand that could be related to the severity of the disease and low sample size. 21 Ocular symptoms were found to be present in 2-32% of COVID-19-infected patients. 15, 25 The prevalence rate of acute conjunctivitis has been shown to range from 1.1% to 31.6%. 2 The study by Bozkurt et al. 30 found that COVID-19 patients showed pathological conjunctival abnormalities and that pathological ocular surface abnormalities can occur even before clinically relevant ocular manifestations. Because viral RNA was found in 7% of patients' conjunctival secretions, the possibility of ocular transmission should be considered even in the absence of visual symptoms. 22, 31 Conjunctivitis was the most common ocular condition among COVID-19 patients, accounting for 88.8% of all reported ocular disorders such as foreign body sensation, tearing, and dry eyes. According to the findings, one out of every 10 COVID-19 patients had at least one eye symptom. The sensitivity of COVID-19 detection among patients can be improved by paying attention to ocular symptoms, particularly conjunctivitis. 32 Positive upper respiratory infection symptoms were linked with conjunctival congestion in these patients. 3 Conversely, meta-analysis study showed that the non-severe COVID-19 patients appearing to be more likely to develop conjunctivitis. 33 Ocular symptoms might develop as a prodromal symptom in the presymptomatic phase (12.5%, 13/104 cases), implying viral transfer through the conjunctiva 34 and due to viral shedding of tears, extreme care must be taken. 22, 35, 36 Conjunctival injection was the most frequent ocular abnormality, followed by visual changes and ocular irritation. 37 Méndez Mangana et al. 38 reported the first 31 White female who had episcleritis in a COVID-19-positive patient. Sriwastava et al. 39 reported the first case of myasthenia gravis in a 65-year-old female COVID-19positive patient. HSV-1 keratitis had been reported in five cases. 40 Other ocular manifestations include dry eye syndrome and episcleritis. 41 Follicular conjunctivitis, 9,41-44 conjunctival hyperemia, 11 chemosis, epiphora, and increased secretions have been reported. 2, 28 Increased conjunctival secretions, ocular pain, 9 ocular discharge and redness, 9 photophobia, dry eye, tearing, and conjunctival congestion, as well as xerophthalmia and keratitis, are chronic COVID-19 ocular manifestations. 26 Acute follicular conjunctivitis with preauricular lymphadenopathy (LAP) and anterior uveitis were observed. 45 Other study reported severe viral conjunctivitis with pseudomembranes on the tarsal conjunctiva with enlarged submaxillaries and preauricular lymph nodes. 46 Hemorrhagic conjunctivitis with pseudomembranes was reported in a 63-year-old male COVID-19 patient. 47 In one case study, a 53-year-old white male COVID-19 patient was diagnosed with blepharitis, and he was advised to keep using the warm compresses and take 100 mg of doxycycline if the symptoms persisted or did not improve. 48 This study found the same rate of positive findings in groups with and without conjunctivitis, indicating that identifying SARS-CoV-2 in ocular secretions is not dependent on conjunctivitis. 5

The SARS-CoV-2 virus can produce ocular symptoms such as viral conjunctivitis. Infected individuals with conjunctivitis and fever may benefit from conjunctival sampling. 49 As a diabetic, hypertensive, and asthmatic 65-year-old COVID-19 patient, while on a ventilator, he developed severe follicular conjunctivitis of the right eye. The resolution of visual symptoms was observed over a period of 2 weeks with no problems. This case discussed and illustrated the sequence of events in individuals with COVID-19 infection who have long COVID-19 late ophthalmic symptoms. 50 During a lengthy COVID-19 lockdown, contact lens compliance was low, particularly in terms of handwashing and storage case cleanliness, emphasizing the necessity for patient-practitioner communication methods to reduce the risk of ocular transmission and viral tropism. 51 Despite the fact that the influence of eye allergy on everyday activities and emotions was limited, the influence of eye allergy symptoms during the quarantine period was determined to be considerable. 52 In conclusion, long-term COVID-19 patient follow-up is recommended to identify any posterior segment manifestations that may develop over time.

Diplopia, ocular pain, and myasthenia gravis are among the reported neuro-ophthalmology signs and symptoms. 66, 67 Vertical diplopia has been present for 10 days in a 58-year-old male. Internuclear ophthalmoplegia was suspected based on extraocular movement testing findings. 68 Fever, cough, and headache were followed by retro-ocular pain and reading impairment in a 51-year-old woman. She was diagnosed with Adie's syndrome and multifocal chorioretinitis. 66 Lidder et al. 69 reported the first case of a Kawasakilike syndrome in a COVID-19-infected adult.

A 25-year-old man with no history of coagulopathy was reported to have experienced a COVID-19 cytokine storm, which resulted in Lock In Syndrome secondary to pontine strokes. 70 The neurological symptoms linked with acute COVID-19 include acute cerebellar ataxia and myoclonus (ACAM) with or without opsoclonus. 71 Myasthenia gravis has been diagnosed in a 21-year-old female COVID-19 patient. 67 Table 1 summarizes the ocular manifestations.

The risk factors of ocular involvement include older age, high fever, elevated neutrophil/lymphocyte ratio, and elevated levels of acute phase reactants. 81 Finally, the presence of neuro-ophthalmologic symptoms may increase the viral infection likelihood, especially if fever and respiratory symptoms are present.

The 

References Prevalence rate of ocular symptoms 2-32%

Aggarwal et al. 9 Al-Namaeh 15 Ulhaq and Soraya 25

Prevalence rate of conjunctivitis 1.1-15.9%

Wu et al. 2 Chen et al. 26 Lai et al. 23 Al-Namaeh 15

Colavita et al. 72 Daruich et al. 28 Drozd et al. 24 Karimi et al. 22 Lai et al. 23 Liu et al. 33 Salducci and La Torre 46 Wu et al. 2 Xia et al. 6 Zhang et al. 73 Hemorrhagic conjunctivitis Rokohl et al. 41 Conjunctival hyperemia Chen et al. 26 Drozd et al. 24 Lai et al. 23 Wu et al. 2 Chemosis Drozd et al. 24 Lai et al. 23 Salducci and La Torre 46 Wu et al. 2 Epiphora Drozd et al. 24 Lai et al. 23 Wu et al. 2 Follicular conjunctivitis Benito-Pascual et al. 61 Wu et al. 2 Increased secretions Drozd et al. 24 Lai et al. 23 Wu Goyal et al. 65 Goyal et al. 65 Shah et al. 58 Paracentral acute middle maculopathy,, voriconazole-induced visual complaints Central serous chorioretinopathy Goyal et al. 65 Sanjay et al. 64 

Bilateral conjunctivitis Colavita et al. 72 Pirraglia et al. 78 Conjunctival hyperemia Abrishami et al. 79 Meduri et al. 80 Chemosis Abrishami et al. 79 Meduri SARS-CoV-2 transmission through tears may be possible, despite the low incidence and rapid resolution of viral presence in the conjunctiva, even in patients who do not appear to have ocular involvement. 77 Late-onset rash and transient loss of taste were reported by a 15-year-old boy. Furthermore, infection with the SARS-CoV-2 virus in children and adolescents can be asymptomatic, but it can also cause fever, dry cough, tiredness, and gastrointestinal symptoms. 86 Conversely, some studies did not report any ocular manifestations of COVID-19 in children. 73, 87 The most common symptoms and signs in 551 COVID-19 children aged 1-17.5 years old were 53% fever, 39% cough, and 14% sore throat/pharyngeal erythema; however, 18% were asymptomatic. 73 74% of patients were administrated antivirals, six patients required invasive mechanical ventilation, and one of them died.

Only a few studies in the geriatric population and children have been published. To assess the ocular symptoms in children and geriatric patients, more retrospective studies are needed.

The probability of viral transmission through tears is much higher in patients with moderate to severe COVID-19. For RT-PCR tear collection, the conjunctival swab remains the gold standard. In addition, wearing eye protection when seeing patients on a daily basis during the pandemic is essential. Follicular conjunctivitis, conjunctival hyperemia, chemosis, and epiphora are the most prevalent ocular symptoms in adults. Optic neuritis, disk edema, retinal artery occlusions, intraretinal hemorrhages, cotton wool spots, and uveitis have all been reported in COVID-19 patients as posterior segment ocular manifestations. Finally, neuro-ophthalmology signs and symptoms include ocular pain, diplopia, and myasthenia gravis. Long-term follow-up is advised to determine the long-term COVID-19 ocular manifestations that may develop over time. Finally, more retrospective studies in the geriatric and pediatric populations are required. 

The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

The author received no financial support for the research, authorship, and/or publication of this article.

Mashael Al-Namaeh https://orcid.org/0000-0002-5253-1175

Are eyes the windows to COVID-19? Systematic review and meta-analysis

Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19

Central retinal vein occlusion in a young healthy COVID-19 patient: a case report

Presence of SARS-CoV-2 viral RNA in aqueous humor of asymptomatic individuals

Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19

Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection

Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients

Evaluation of SARS-CoV-2 in tears of patients with moderate to severe COVID-19

Ocular surface manifestations of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis

Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease

Recurrent keratoconjunctivitis as the sole manifestation of COVID-19 infection: a case report

COVID-19 in the light of current clinical eye research

Frequency of ophthalmological findings in hospitalized COVID-19 patients

COVID-19 and conjunctivitis: a meta-analysis

Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Ophthalmic manifestations in the COVID-19 clinical spectrum

Unilateral conjunctivitis as first presentation of coronavirus disease 2019 (COVID-19): a telemedicine diagnosis

Ocular manifestation, eye protection, and COVID-19

Detection of severe acute respiratory syndrome coronavirus-2 in the tears of patients with coronavirus disease

Extra-respiratory manifestations of COVID-19

Cutaneous cytomegalovirus manifestations, diagnosis, and treatment: a review

The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid

Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study

Ocular features and associated systemic findings in SARS-CoV-2 infection

Ocular manifestation as first sign of coronavirus disease 2019 (COVID-19): interest of telemedicine during the pandemic context

Conjunctivitis as sole symptom of COVID-19: a case report and review of literature

Ocular surface and conjunctival cytology findings in patients with confirmed COVID-19

A special on epidemic prevention and control: ophthalmologic research and prevention of 2019 novel coronavirus based on ocular manifestations of viral diseases

Ocular manifestations of COVID-19: a systematic review and meta-analysis

Letter to the editor: are severe COVID-19 patients more susceptible to conjunctivitis

Clinical and prodromal ocular symptoms in coronavirus disease: a systematic review and meta-analysis

Detection of SARS-CoV-2 in the tears and conjunctival secretions of coronavirus disease 2019 patients

Ocular manifestations of hospitalized COVID-19 patients in a tertiary care academic medical center in the United States: a cross-sectional study

Episcleritis as an ocular journals.sagepub.com/home/oed manifestation in a patient with COVID-19

New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review

Herpes simplex keratitis in patients with SARS-CoV-2 infection: a series of five cases

Ocular involvement in COVID-19: conjunctivitis and more

The ocular manifestations and transmission of COVID-19: recommendations for prevention

COVID-19 and the ocular surface: a review of transmission and manifestations

Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: a retrospective cross-sectional study

Outcomes of the ophthalmic examinations in patients infected by SARS-CoV-2

COVID-19 emergency in the cruise's ship: a case report of conjunctivitis

Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2

The ocular manifestations of COVID-19 through conjunctivitis

Acute onset of bilateral follicular conjunctivitis in two patients with confirmed SARS-CoV-2 infections

Late manifestation of follicular conjunctivitis in ventilated patient following COVID-19 positive severe pneumonia

Patient -practitioner communication and contact lens compliance during a prolonged COVID-19 lockdown

Impact of quarantine during COVID-19 pandemic on the quality of life of patients with allergic conjunctivitis

Unilateral inferior altitudinal visual field defect related to COVID-19

Acute macular neuroretinopathy as the presenting manifestation of COVID-19 infection

Retinal vein occlusion in COVID-19: a novel entity

A case of bilateral unusual retinal hemorrhages in a COVID-19 patient

COVID-19-related ocular hypertension secondary to anterior uveitis as part of a multisystemic inflammatory syndrome

A case series of presumed fungal endogenous endophthalmitis in post COVID-19 patients

Unilateral frosted branch angiitis in an human immunodeficiency virus-infected patient with concurrent COVID-19 infection: a case report

Post COVID-19 ophthalmic manifestations in an Asian Indian male

Panuveitis and optic neuritis as a possible initial presentation of the novel coronavirus disease 2019 (COVID-19)

Ocular MRI findings in patients with severe COVID-19: a retrospective multicenter observational study

Cavernous sinus thrombosis with central retinal artery occlusion in COVID-19: a case report and review of literature

Old wine in a new bottle' -post COVID-19 infection, central serous chorioretinopathy and the steroids

Retinal manifestations in patients following COVID-19 infection: a consecutive case series

Ophthalmic and neuroophthalmic manifestations of coronavirus disease 2019 (COVID-19)

Postinfectious onset of myasthenia gravis in a COVID-19 patient

Internuclear ophthalmoplegia as a presenting feature in a COVID-19-positive patient

An adult with COVID-19 Kawasaki-like syndrome and ocular manifestations

Locked-in with COVID-19

Acute cerebellar ataxia and myoclonus with or without opsoclonus: a parainfectious syndrome associated with COVID-19

SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection

What we know so far about coronavirus disease 2019 in children: a meta-analysis of 551 laboratoryconfirmed cases

Ocular manifestations and clinical characteristics of children with laboratory-confirmed COVID-19 in Wuhan, China

Ophthalmic manifestations associated with SARS-CoV-2 in newborn infants: a preliminary report

Central retinal vein occlusion with COVID-19 infection as the presumptive etiology

Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report

Retinal involvement and ocular findings in COVID-19 pneumonia patients

Ocular manifestations of hospitalized patients with COVID-19 in Northeast of Iran

Ocular surface manifestation of COVID-19 and tear film analysis

Ocular manifestations of coronavirus disease 2019

Visual tests predict dementia risk in Parkinson disease

Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children

Ocular assessments of a series of newborns gestationally exposed to maternal COVID-19 infection

Bilateral acute anterior uveitis and corneal punctate epitheliopathy in children diagnosed with multisystem inflammatory syndrome secondary to COVID-19

A case of COVID-19 with late-onset rash and transient loss of taste and smell in a 15-year-old boy

COVID-19 epidemic: disease characteristics in children